Metraipolis › archive › dc_98a781ee398f
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy — Europe PMC PMID:41917280
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41917280
- DOI
- 10.1038/s41375-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T15:28:20.745Z
- SHA-256 of the archived text
f4e0602dcaae74f1f831c0af9da913f46edc731deaf6f1df0a2e822da087ff15- Stable URL of this page
https://metraipolis.com/documento/dc_98a781ee398f
How to cite
Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy — Europe PMC PMID:41917280 — Europe PMC (en), https://europepmc.org/article/MED/41917280 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98a781ee398f (Metraipolis archive dc_98a781ee398f, sha256 f4e0602dcaae74f1f831c0af9da913f46edc731deaf6f1df0a2e822da087ff15)
BibTeX
@misc{dc98a781ee398f,
title = {Loss of GPRC5D enhances the proliferative capacity and competitive fitness of myeloma upon anti-GPRC5D immunotherapy — Europe PMC PMID:41917280},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41917280},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98a781ee398f; sha256 f4e0602dcaae74f1f831c0af9da913f46edc731deaf6f1df0a2e822da087ff15},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41917280. Agents can read the archived copy with the MCP tool read_document.